We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLSD
2676
DELISTED
Clearside Biomedical
CLSD
$8K ﹤0.01%
515
+457
+788% +$8.15K
CLVT icon
2677
Clarivate
CLVT
$1.16B
$8K ﹤0.01%
+500
New +$6.97K
CORT icon
2678
Corcept Therapeutics
CORT
$12B
$8K ﹤0.01%
+679
New +$7.57K
CRMT icon
2679
America's Car Mart
CRMT
$26.9M
$8K ﹤0.01%
89
-225
-72% -$20.7K
HERZ
2680
Herzfeld Credit Income Fund
HERZ
$31.6M
$8K ﹤0.01%
161
-2
-1% -$95
CVM icon
2681
CEL-SCI Corp
CVM
$30.1M
$8K ﹤0.01%
+33
New +$5.97K
CWEB icon
2682
Direxion Daily CSI China Internet Index Bull 2X ETF
CWEB
$256M
$8K ﹤0.01%
35
-14
-29% -$3.62K
CYRX icon
2683
CryoPort
CYRX
$762M
$8K ﹤0.01%
462
-19
-4% -$302
DBVT
2684
DBV Technologies
DBVT
$847M
$8K ﹤0.01%
97
-163
-63% -$14.6K
ERY icon
2685
Direxion Daily Energy Bear 2X ETF
ERY
$41.9M
$8K ﹤0.01%
19
-2,141
-99% -$931K
GOGL
2686
DELISTED
Golden Ocean Group
GOGL
$8K ﹤0.01%
1,438
-4,636
-76% -$24.3K
HNRG icon
2687
Hallador Energy
HNRG
$696M
$8K ﹤0.01%
1,349
-15,059
-92% -$81.2K
HURC icon
2688
Hurco Companies Inc
HURC
$143M
$8K ﹤0.01%
+231
New +$8.73K
JRSH icon
2689
Jerash Holdings
JRSH
$63.5M
$8K ﹤0.01%
1,159
+732
+171% +$5.16K
LSTA icon
2690
Lisata Therapeutics
LSTA
$9.55M
$8K ﹤0.01%
+234
New +$10.4K
MBCN
2691
DELISTED
Middlefield Banc Corp
MBCN
$8K ﹤0.01%
400
-1,196
-75% -$24K
MLP icon
2692
Maui Land & Pineapple Co
MLP
$344M
$8K ﹤0.01%
736
+204
+38% +$2.24K
MSEX icon
2693
Middlesex Water
MSEX
$1.1B
$8K ﹤0.01%
+142
New +$8.25K
MVIS icon
2694
Microvision
MVIS
$79M
$8K ﹤0.01%
+623
New +$8.3K
NGNE icon
2695
Neurogene
NGNE
$712M
$8K ﹤0.01%
164
-80
-33% -$4.11K
NKTR icon
2696
Nektar Therapeutics
NKTR
$2.58B
$8K ﹤0.01%
14
-553
-98% -$277K
OCUL icon
2697
Ocular Therapeutix
OCUL
$2.02B
$8K ﹤0.01%
1,921
-12,187
-86% -$45.1K
PAYS icon
2698
Paysign
PAYS
$705M
$8K ﹤0.01%
561
-3,814
-87% -$36.3K
PEY icon
2699
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.17B
$8K ﹤0.01%
451
+266
+144% +$4.77K
PFLT icon
2700
PennantPark Floating Rate Capital
PFLT
$746M
$8K ﹤0.01%
674
-648
-49% -$8K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.